HALO
HALOZYME THERAPEUTICS INC
Latest close $83.59 as of Aug 5, 2026
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred
from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
Free access includes current parsed ownership filings, reported share changes, and ownership-percentage changes.
Significance scoring, disclosure-speed analysis, confirmation/divergence signals, and signal alerts require Investor or Pro.
Compare plans.
Beneficial ownership filing history
Showing 3 of 4 parsed filing(s) · 1 older require more history access| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| State Street CIK0000093751 | Mar 31, 2025 observed May 13, 2025 filed · 43d Initial Schedule 13G | Initial Schedule 13G | 6.1M | 12.00% | $63.81 | $50.23 | $83.59 |
| BlackRock Legacy CIK0001364742 | Dec 31, 2023 observed Jan 23, 2024 filed · 23d Schedule 13G amendment | Earliest Schedule 13G amendment found | 18.6M | 14.10% | $83.59 | ||
| Invesco CIK0000914208 | Dec 29, 2023 observed Feb 1, 2024 filed · 34d Schedule 13G amendment | Exit below reporting threshold | 2.8M -4.2M | 2.10% -3.10 pts | $83.59 |